Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 11:00 ET | Source: Devon Energy Corporation

Devon Energy Schedules First-Quarter 2026 Earnings Release and Conference Call

OKLAHOMA CITY, April 08, 2026 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today announced it will report first-quarter 2026 results on Tuesday, May 5, after the close of U.S. financial...
April 07, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Notes Sarborg Publication of PRISM Framework Expanding AI
April 06, 2026 08:00 ET | Source: Pomerantz LLP

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR

SAINT PAUL, Minn., April 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A. announce that the United States District Court District of Minnesota has approved the following...
April 01, 2026 07:00 ET | Source: Rapport Therapeutics, Inc.

Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and...
March 31, 2026 16:37 ET | Source: Kirby Corporation

Kirby Corporation Announces Date for 2026 First Quarter Earnings Release and Earnings Webcast

HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- Kirby Corporation ("Kirby") (NYSE: KEX) will announce its 2026 first quarter results at 6:00 a.m. Central Daylight Time (“CDT”) on Thursday, April 30,...
March 26, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
March 25, 2026 08:00 ET | Source: CDT Equity Inc.

CDT Equity Inc. Announces Reverse Stock Split

CDT Equity Inc. Announces Reverse Stock Split
March 23, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026 08:00 ET | Source: NewAmsterdam Pharma N.V.

NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session

NAARDEN, The Netherlands and MIAMI, March 23, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
March 23, 2026 07:30 ET | Source: Cabaletta Bio

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Rese-cel myositis BLA submission on track for 2027 based on a 17-patient, single arm registrational cohort design, including an outpatient dosing option No-preconditioning program enrolling in lupus...